Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
YH Khor, Y Ng, H Barnes, NSL Goh… - European …, 2020 - Eur Respiratory Soc
In addition to facilitating healthcare delivery planning, reliable information about prognosis is
essential for treatment decisions in patients with idiopathic pulmonary fibrosis (IPF). This …
essential for treatment decisions in patients with idiopathic pulmonary fibrosis (IPF). This …
Ventajas de un ensayo inmunomodulador para la determinación de la potencia in vitro del interferón gamma humano
LGS Coma, HG Pérez, DCB López… - Biotecnología …, 2018 - medigraphic.com
Los productos biotecnológicos que contienen el interferón gamma humano recombinante
(IFNγ-hr) como ingrediente farmacéutico activo constituyen soluciones terapéuticas …
(IFNγ-hr) como ingrediente farmacéutico activo constituyen soluciones terapéuticas …
[PDF][PDF] Advantages of an immunomodulatory assay for the determination of the in vitro potency of human gamma interferon
LGS Coma, HG Pérez, DCB López… - Biotecnología …, 2018 - elfosscientiae.cigb.edu.cu
Products containing human interferon human recombinant gamma interferon (IFNγ-hr) as
active pharmaceutical ingredients are promising alternatives for treating juvenile rheumatoid …
active pharmaceutical ingredients are promising alternatives for treating juvenile rheumatoid …
[PDF][PDF] Adjuvant Interferon Gamma in the Management of Multidrug-Resistant Tuberculosis
I García-García - Edited by Pere-Joan Cardona, 2012 - pdfs.semanticscholar.org
Tuberculosis is an opportunistic infection, the minute it finds an immunocompromised host, it
flourishes. The risk of tuberculosis is much higher in patients who are human …
flourishes. The risk of tuberculosis is much higher in patients who are human …